The FDA also cleared the SmartGuard algorithm enabling integration with the Instinct, a new sensor made by Abbott.

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that broaden the MiniMed™ 780G system portfolio: ...

Medtronic (NYSE:MDT) announced on Tuesday that the U.S. FDA cleared its SmartGuard algorithm as an interoperable automated ...

Medtronic has obtained a pair of major green lights from the FDA for its flagship insulin pump—opening up the MiniMed 780G to adults with type 2 diabetes in the U.S., and allowing it to c | ...

Medtronic has received clearance for its SmartGuard algorithm as an interoperable automated glycemic controller (iAGC), enabling integration with Abbott’s Instinct sensor for Type ...

The announcement comes just after Dexcom, another diabetes company, released its own consumer-friendly sensor. Here's what to know about glucose monitoring.

Penn State engineers built a graphene-based breath sensor that detects acetone, offering quick, low-cost diabetes and ...

An experimental breath test successfully sorted out type 2 diabetes patients from healthy people, based on their exhalations, ...

A research team led by Huanyu “Larry” Cheng, James L. Henderson, Jr. Memorial Associate Professor of Engineering Science and ...